Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis
Conditions: Desmoid Tumors; Aggressive FibromatosisIntervention: Drug: PF-03084014Sponsors: National Cancer Institute (NCI); National Institutes of Health Clinical Center (CC)Active, not recruiting - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials